Try our beta test site
13 studies found for:    inno-206
Show Display Options
Rank Status Study
1 Completed Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors
Condition: Malignant Solid Tumour
Intervention: Drug: INNO-206
2 Completed Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: INNO-206
3 Completed Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumor
Intervention: Drug: aldoxorubicin
4 Completed Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: aldoxorubicin
5 Unknown  Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
Conditions: Metastatic Soft Tissue Sarcoma;   Locally Advanced Soft Tissue Sarcoma;   Unresectable Soft Tissue Sarcoma
Interventions: Drug: INNO-206;   Drug: Doxorubicin
6 Completed Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
Condition: Glioblastoma
Intervention: Drug: aldoxorubicin
7 Withdrawn INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: INNO-206
8 Completed A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma;   HIV+;   HIV Positive;   AIDS
Intervention: Drug: aldoxorubicin
9 Unknown  Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors
Condition: Metastatic Solid Tumors
Interventions: Drug: aldoxorubicin;   Drug: gemcitabine
10 Recruiting Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma
Condition: Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
Interventions: Drug: aldoxorubicin;   Drug: ifosfamide
11 Recruiting Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Condition: Metastatic Small Cell Lung Cancer
Interventions: Drug: Aldoxorubicin;   Drug: Topotecan
12 Active, not recruiting Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Condition: Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
Interventions: Drug: Aldoxorubicin;   Drug: Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
13 No longer available Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy
Condition: Sarcoma
Intervention: Drug: aldoxorubicin

Study has passed its completion date and status has not been verified in more than two years.